Medicina y ciencias biológicas
Tumor-Infiltrating Lymphocytes
100%
Breast Neoplasms
76%
Triple Negative Breast Neoplasms
42%
Hydroxymethylglutaryl-CoA Synthase
38%
Peru
32%
Glioblastoma
28%
Intestines
27%
Neoplasms
27%
Biomarkers
22%
Helicobacter pylori
21%
Stomach Neoplasms
21%
Drug Therapy
20%
Survival
17%
Regulator Genes
17%
Liver
17%
Carnitine
15%
Messenger RNA
14%
Mutation
13%
Transferases
13%
Risk Management
12%
Helicobacter Infections
11%
2-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide
11%
Genes
11%
Latin America
10%
Polymerase Chain Reaction
10%
Dexamethasone
10%
Ovarian Neoplasms
10%
Methylation
10%
Hispanic Americans
10%
Hematoxylin
9%
Staining and Labeling
9%
Pathologists
9%
Clinical Trials
9%
MicroRNAs
9%
Tuberculosis
9%
BRCA2 Gene
9%
Carica
8%
Therapeutics
8%
Eosine Yellowish-(YS)
8%
Gene Expression
8%
Circulating Tumor DNA
8%
Anthracyclines
8%
Paraffin
8%
Colombia
7%
Carnitine O-Palmitoyltransferase
7%
Genotype
7%
Letrozole
7%
Neoadjuvant Therapy
7%
BRCA1 Gene
7%
Amebiasis
7%
Estrogen Receptors
7%
Multiplex Polymerase Chain Reaction
7%
DNA
7%
Immunohistochemistry
7%
Radiotherapy
7%
Population
7%
Gastritis
7%
Capecitabine
7%
Disease-Free Survival
7%
Dystrophin
6%
Exons
6%
Residual Neoplasm
6%
Melanoma
6%
Ketone Bodies
6%
Brain Neoplasms
6%
Carcinoma in Situ
6%
Papillomavirus Infections
6%
Docetaxel
6%
Methyltransferases
6%
ErbB Receptors
6%
Cytomegalovirus Infections
6%
Pyruvic Acid
5%
Encephalitis
5%
Neoplastic Stem Cells
5%
Fluorescein
5%
Caricaceae
5%
Weaning
5%
Seeds
5%
Mexico
5%
Head and Neck Neoplasms
5%
Oils
5%
Human Herpesvirus 4
5%
Restriction Fragment Length Polymorphisms
5%
Fruit
5%
Proteomics
5%
Small Intestine
5%